Chronic kidney disease trials in Hungary

In Hungary 11 Also abroad 798

11 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
Budapest, Budapest III, Budapest VIII, Budapest XVIII, Dunaujvaros, Gyor, Kaposvar, Nyíregyháza, Szeged, Székesfehérvár, Szolnok, Zalaegerszeg
Age
18 years and over
People
5,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
Phase 3Taking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Balatonfüred, Budapest III, Budapest IV, Budapest VIII, Budapest X, Budapest XIII, Budapest XIV, Debrecen, Encs, Kecskemét, Kistarcsa, Nyíregyháza, Szeged, Székesfehérvár, Zalaegerszeg
Age
50 years and over
People
7,140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
No phaseEnrolling by invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Where
Szeged
Age
0 Minutes to 2 weeks
People
8,000 worldwide
Run by
Indiana University
See details and how to joinNCT06823115
Phase 3Taking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Debrecen, Pécs, Szeged
Age
18 years to 100 years
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
Phase 3Taking people
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Where
Budapest VIII, Debrecen, Pécs, Szeged
Age
1 year to 18 years
People
100 worldwide
Run by
Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Kaposvár, Kistarcsa
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
Phase 3Taking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Budapest III, Budapest VIII, Budapest XI, Budapest XIII, Gyula, Kalocsa, Nagykanizsa, Nyíregyháza, Szeged, Szigetvar
Age
18 years and over
People
7,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
Phase 3Taking people
A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
Where
Budapest, Szeged
Age
2 years to 17 years
People
24 worldwide
Run by
Amgen
See details and how to joinNCT03969329 · EU 2023-506471-10-00
No phaseTaking people
International (Pediatric) Peritoneal Biobank
Where
Budapest
Age
1 day to 90 years
People
500 worldwide
Run by
Heidelberg University
See details and how to joinNCT01893710
Phase 3Taking people
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
Where
Szeged
Age
2 years to 17 years
People
129 worldwide
Run by
AMAG Pharmaceuticals, Inc.
See details and how to joinNCT03619850 · EU 2024-516263-92-00
No phaseTaking people
Cardiovascular Risk in Children With Chronic Conditions Study
Where
Budapest
Age
6 years to 25 years
People
300
Run by
Semmelweis University
See details and how to joinNCT07086989